Literature DB >> 15872194

Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Benedikt Fischer1, Jürgen Rehm, Suzanne Brissette, Serge Brochu, Julie Bruneau, Nady El-Guebaly, Lina Noël, Mark Tyndall, Cameron Wild, Phil Mun, Dolly Baliunas.   

Abstract

Most of the estimated 125,000 injection drug users (IDUs) in Canada use illicit opioids and are outside treatment (i.e., methadone maintenance treatment). Empirical data suggest that illicit opioid users outside treatment are characterized by various health and social problem characteristics, including polydrug use, physical and mental morbidity, social marginalization, and crime. Although required for evidence-based programming, systematic information on this specific substance-user population is sparse in Canada to date. This article presents and compares key characteristics of population of illicit opioid users outside treatment in five cities across Canada (OPICAN cohort). Overall, the majority of OPICAN participants regularly used both a variety of illicit opioids and cocaine or crack, reported physical and mental health (e.g., mood disorder) problems, lacked permanent housing, were involved in crime, and had their "ideal" treatment not available to them. However, key local sample differences were shown, including patterns of heroin versus prescription opioid use and levels of additional cocaine versus crack use as well as indicators of social marginalization. Illicit opioid user population across Canada differ on key social, health, and drug use indicators that are crucial for interventions and are often demonstrated between larger and smaller city sites. Differentiated interventions are required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872194      PMCID: PMC3456573          DOI: 10.1093/jurban/jti049

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  61 in total

1.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  First use of heroin: changes in route of administration over time.

Authors:  J Strang; P Griffiths; B Powis; M Gossop
Journal:  BMJ       Date:  1992-05-09

Review 3.  Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients.

Authors:  Eric C Strain
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

Review 4.  Accuracy of oral specimen testing for human immunodeficiency virus.

Authors:  W Emmons
Journal:  Am J Med       Date:  1997-04-01       Impact factor: 4.965

5.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

6.  Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors.

Authors:  P Griffiths; M Gossop; B Powis; J Strang
Journal:  Addiction       Date:  1994-03       Impact factor: 6.526

7.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

Review 8.  Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Authors:  H Joseph; S Stancliff; J Langrod
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

9.  Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users.

Authors:  E J van Ameijden; J A van den Hoek; C Hartgers; R A Coutinho
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

10.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien; K A Druley
Journal:  Arch Gen Psychiatry       Date:  1983-06
View more
  42 in total

1.  Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico.

Authors:  Dan Werb; Steffanie A Strathdee; Alicia Vera; Jaime Arredondo; Leo Beletsky; Patricia Gonzalez-Zuniga; Tommi Gaines
Journal:  Addiction       Date:  2016-04-28       Impact factor: 6.526

2.  Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.

Authors:  Emma Haydon; Benedikt Fischer
Journal:  Can J Public Health       Date:  2005 May-Jun

3.  Changes in illicit opioid use across Canada.

Authors:  Benedikt Fischer; Jürgen Rehm; Jayadeep Patra; Michelle Firestone Cruz
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

4.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

5.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

6.  Negotiating the Relationship Between Addiction, Ethics, and Brain Science.

Authors:  Daniel Z Buchman; Wayne Skinner; Judy Illes
Journal:  AJOB Neurosci       Date:  2010-01

7.  Impact of a methadone maintenance program on an Aboriginal community: a qualitative study.

Authors:  Michel Landry; Nadia Veilleux; Julie-Eve Arseneault; Saneea Abboud; André Barrieau; Mathieu Bélanger
Journal:  CMAJ Open       Date:  2016-08-17

8.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

9.  Days of heroin use predict poor self-reported health in hospitalized heroin users.

Authors:  Lidia Z Meshesha; Judith I Tsui; Jane M Liebschutz; Denise Crooks; Bradley J Anderson; Debra S Herman; Michael D Stein
Journal:  Addict Behav       Date:  2013-08-14       Impact factor: 3.913

10.  Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.

Authors:  Laurie Cloutier-Gill; Evan Wood; Trevor Millar; Caroline Ferris; M Eugenia Socias
Journal:  J Psychoactive Drugs       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.